The Department of Defense offers the PRMRP Technology/Therapeutic Development Award to support translating preclinical findings into clinical applications for healthcare needs of military Service members, Veterans, and/or beneficiaries. Projects can include pharmacologic agents, devices, or knowledge-based products. Researchers must provide a transition plan for advancing the product post-award. Applications for this grant close on October 15, 2015.
Opportunity ID: 275975
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-15-PRMRP-TTDA |
| Funding Opportunity Title: | DoD Peer Reviewed Medical Technology/Therapeutic Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 10 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 17, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 15, 2015 |
| Current Closing Date for Applications: | Oct 15, 2015 |
| Archive Date: | Nov 14, 2015 |
| Estimated Total Program Funding: | $27,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The PRMRP Technology/Therapeutic Development Award is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, in at least one of the Congressionally directed FY15 PRMRP Topic Areas. Products in development should be responsive to the healthcare needs of military Service members, Veterans, and/or beneficiaries. The product(s) to be developed may be a tangible item such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product such as clinical guidance for standard of care. The Principal Investigator (PI) must provide a transition plan (including potential funding and resources) showing how the product will progress to the next level of development (e.g., clinical trials, delivery to the military or civilian market) after the completion of the PRMRP award. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
help@eBRAP.org; 301-682-5507
Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 275975 Full Announcement-1 -> prmrp fy15 ttda_gg.pdf
Packages
| Agency Contact Information: | help@eBRAP.org; 301-682-5507 Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00216275 | Apr 17, 2015 | Oct 15, 2015 | View |
Package 1
Mandatory forms
275975 RR_SF424_2_0-2.0.pdf
275975 RR_Budget_1_3-1.3.pdf
275975 RR_KeyPersonExpanded_2_0-2.0.pdf
275975 PerformanceSite_2_0-2.0.pdf
Optional forms
275975 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
